Issuu on Google+

Transparency Market Research (TMR) provides a range of marketing and business research solutions designed for your specific needs. From off-the-shelf syndicated business & market research to made-to-order custom research, we serve our clients to fulfill their immediate as well as ongoing research requirements.

Contact Us : State Tower,90 State Street,Suite 700,Albany NY – 12207,United States Tel: +1-518-618-1030

Email: sales@transparencymarketresearch.com


Non-Invasive Prenatal Testing (NIPT) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Single User License: US $ 4795

Multi User License: US $ 7795

Corporate User License: US $ 10795

Single User License

US $ 4795

Multi User License

US $ 7795

Corporate User License

US $ 10795

Buy Now Request Sample

68 Pages Report

Published Date : Jan 2014


PR : Non-Invasive Prenatal Testing (NIPT) Market Expected to Reach USD 3.62 Billion Globally in 2019: Transparency Market Research

Transparency Market Research is Published new Market Report Non-Invasive Prenatal Testing (NIPT) Market (MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest and BambniTest) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global NIPT market was valued at USD 0.22 billion in 2012 and is expected to grow at a CAGR of 37.6% from 2013 to 2019, to reach an estimated value of USD 3.62 billion in 2019. The market for non-invasive prenatal testing is evolving rapidly due the advantages it offers over the conventional prenatal screening and diagnostic methods such as maternal serum screening, nuchal translucency (NT) scan, amniocentesis and chorionic villus sampling (CVS). These advantages include safety, accuracy, and no risk of miscarriage. An NIPT is a non-invasive genetic screening test for the common chromosomal abnormalities (trisomy 21, trisomy 18, trisomy 13, monosomy X, etc.) observed in the fetuses of high risk pregnant women (above the age of 35 years). Owing to its ability to detect the presence of chromosomal abnormalities in fetuses of pregnant women as early as 9 to 10 weeks of gestation, the market for non-invasive prenatal testing is witnessing a rapid increase in demand from all parts of the world. MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest and BambniTest are the commercially available NIPTs in the market which are based on the direct analysis of cellfree fetal DNA in the maternal blood. In 2012, MaterniT21 (a proprietary product of Sequenom, Inc.) accounted for the largest share (36.6%) of the global NIPT market in terms of revenue, owing to the fact that it was the first mover in the market place. During the forecast period 2013 to 2019, it is likely to lose some of its share due to increasing market penetration by other aforementioned NIPTs such as Panorama and verifi. High incidence rate of babies born with certain type of chromosomal abnormalities, growing trend of child bearing at advanced maternal age and enhanced popularity of NIPT among gynecologists and high risk pregnant women are some of the major factors anticipated to drive growth of the NIPT market during the forecast period. Some of the most commonly detected chromosomal aneuploidies include Down syndrome, Edwards syndrome, Patau syndrome and monosomy X. On the other hand, ethical and regulatory hurdles are expected to pose significant challenges before the NIPT market to grow. Various professional committees across the world believe that the implementation of NIPT and the subsequent rise in uptake of prenatal testing is likely to increase the incidence of abortions.


Therefore, professional groups such as The American College of Obstetricians and Gynecologists (ACOG), International Society for Prenatal Diagnosis and The Japan Society of Obstetrics and Gynecology have set up guidelines that limit the use of non-invasive prenatal testing only to pregnant women at high risk of chromosomal aneuploidies. Browse the full report with complete TOC at http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnosticsmarket.html Geographically, North America was the largest regional market in 2012 with a market share of 64.5% of the total revenue generated globally, followed by Europe. Almost every company operating in this market is adopting the same business model of marketing their tests via alliances with hospitals, diagnostic laboratories and physician offices. The increasing penetration by test developers in European, Asia-Pacific and Middle-East countries indicates promising growth in the near future in these markets. Sequenom, Inc., Verinata Health, Inc. (now a part of Illumina, Inc.), Ariosa Diagnostics, Natera, Inc., BGI Health, LifeCodexx and Berry Genomics are the companies engaged in providing noninvasive prenatal tests worldwide. The global non-invasive prenatal testing market is segmented as follows: Non-Invasive Prenatal Testing Market, by Test 

MaterniT21 PLUS

verifi

Harmony

Panorama

NIFTY

PrenaTest

BambniTest

Non-Invasive Prenatal Testing Market, by Geography 

North America

Europe

Asia-Pacific

Rest of the World (RoW)


Table of Content

Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Sources 1.3.1.1 Secondary Research 1.3.1.2 Primary Research 1.3.2 Models Related & Recently Published Reports by Transparency Market Research 

Broadcast Switchers Market: http://www.transparencymarketresearch.com/broadcast-switchersmarket.html

Refrigerated Display Cases (Plug-in and Remote) Market: http://www.transparencymarketresearch.com/refrigerated-displaycabinets.html

Physical Security (Hardware, Software and Services) Market: http://www.transparencymarketresearch.com/physical-securitymarket.html

Anti-aging Market: http://www.transparencymarketresearch.com/antiaging-market.html

Teleradiology Market: http://www.transparencymarketresearch.com/teleradiology-technologyMarket.html

Nanomedicine Market: http://www.transparencymarketresearch.com/nanomedicine-market.html


Chapter 2 Executive Summary Chapter 3 Global Non-Invasive Prenatal Testing Market Overview 3.1 Introduction 3.2 Major Chromosomal Aneuploidies and their Incidence Rate 3.2.1 Down Syndrome 3.2.2 Edwards Syndrome 3.2.3 Patau Syndrome 3.2.4 Turner Syndrome 3.2.5 Klinefelter Syndrome 3.2.6 Jacobs Syndrome 3.2.7 Triple X Syndrome 3.3 Technological Approach for NIPT 3.4 Market Drivers 3.4.1 High incidence rate of babies born with Down syndrome 3.4.2 Rise in average maternal age 3.4.3 Increasing demand for early and non-invasive fetal testing procedures 3.5 Market Restraints 3.5.1 Regulatory guidelines and ethical hurdles 3.5.2 Limitations of NIPT 3.5.3 Availability of other screening and testing methods 3.6 Market Opportunities 3.6.1 Capitalizing on the potential presented by the emerging markets of Asia 3.7 Porter’s Five Force Analysis for the Global Non-Invasive Prenatal testing Market 3.7.1 Bargaining power of suppliers 3.7.2 Bargaining power of buyers 3.7.1 Threat of substitutes


3.7.2 Threat of new entrants 3.7.3 Competitive rivalry 3.8 Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography

Chapter 4 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 2019 (USD Million) 4.1 Overview 4.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 – 2019 (USD Million) 4.1.2 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 & 2019 (Value %) 4.2 MaterniT21 PLUS 4.2.1 Global MaterniT21 PLUS Test Market Revenue, 2012 – 2019 (USD Million) 4.3 Harmony Prenatal Test 4.3.1 Global Harmony Test Market Revenue, 2012 – 2019 (USD Million) 4.4 verifi Prenatal Test 4.4.1 Global verifi Test Market Revenue, 2012 – 2019 (USD Million) 4.5 Panorama Test 4.5.1 Global Panorama Test Market Revenue, 2012 – 2019 (USD Million) 4.6 Noninvasive Fetal Trisomy (NIFTY) Test 4.6.1 Global NIFTY Test Market Revenue, 2012 – 2019 (USD Million) 4.7 BambniTest 4.7.1 Global BambniTest Test Market Revenue, 2012 – 2019 (USD Million) 4.8 PrenaTest 4.8.1 Global PrenaTest Test Market Revenue, 2012 – 2019 (USD Million)


Chapter 5 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 - 2019 (USD Million) 5.1 Overview 5.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 2019 (USD Million) 5.1.2 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 & 2019 (Value %) 5.2 North America 5.2.1 North America Non-Invasive Prenatal Testing Market Revenue, 2012 - 2019 (USD Million) 5.3 Europe 5.3.1 Europe Non-Invasive Prenatal Testing Market Revenue, 2012 - 2019 (USD Million) 5.4 Asia-Pacific 5.4.1 Asia-Pacific Non-Invasive Prenatal Testing Market Revenue, 2012 - 2019 (USD Million) 5.5 Rest of the World (RoW) 5.5.1 Rest of the World (RoW) Non-Invasive Prenatal Testing Market Revenue, 2012 2019 (USD Million)

Chapter 6 Competitive Landscape 6.1 Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations 7.1 Focus on improving technology in order to increase the accuracy, reduce the duration of result generation and price 7.2 Focus on forming alliances with diagnostic service providers in European and Asia-Pacific countries 7.3 Mergers and acquisitions


Chapter 8 Company Profiles 8.1 Ariosa Diagnostics, Inc. 8.1.1 Company Overview 8.1.2 Product Portfolio 8.1.3 Business Strategies 8.1.4 Recent Developments 8.2 Berry Genomics Co., Ltd 8.2.1 Company Overview 8.2.2 Product Portfolio 8.2.3 Business Strategies 8.2.4 Recent Developments 8.3 BGI Health 8.3.1 Company Overview 8.3.2 Product Portfolio 8.3.3 Business Strategies 8.4 LifeCodexx AG 8.4.1 Company Overview 8.4.2 Product Portfolio 8.4.3 Business Strategies 8.4.4 Recent Developments 8.5 Natera, Inc. 8.5.1 Company Overview 8.5.2 Product Portfolio 8.5.3 Business Strategies 8.5.4 Recent Developments 8.6 Sequenom, Inc. 8.6.1 Company Overview


8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 Verinata Health, Inc. 8.7.1 Company Overview 8.7.2 Product Portfolio 8.7.3 Recent Developments

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact us :

Sheela AK 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Web: http://www.transparencymarketresearch.com/


Non-Invasive Prenatal Testing (NIPT) Market 2013 - 2019